|
Microarray Analysis for Human Genetic Disease Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Microarray Analysis for Human Genetic Disease conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Microarray Analysis for Human Genetic Disease Clinical research trials and Microarray Analysis for Human Genetic Disease health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Microarray Analysis for Human Genetic Disease. Microarray Analysis for Human Genetic Disease Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Microarray Analysis for Human Genetic Disease clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Microarray Analysis for Human Genetic Disease condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Microarray Analysis for Human Genetic Disease  Microarray Analysis for Human Genetic Disease
Microarray Analysis for Human Genetic Disease
For Condition: Breast Neoplasm,Hereditary Neoplastic Syndrome,Melanoma,Ovarian Neoplasm
Status: Recruiting
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will look at genetic influences in the development of male and female breast cancer and ovarian cancer that run in families. It will use a new technology called cDNA microarray hybridization that looks at a wide array of genes to identify disease-associated patterns in the human genome (complete set of human genes). Numerous studies have linked particular genes to a given disease, but there is very little information on patterns of gene expression (production of proteins from genetic coding) in the entire human genome. Pinpointing genetic abnormalities in disease may help identify individuals at increased risk and perhaps lead to new avenues of treatment or prevention. A primary goal of this study will be to create a database of gene expression for human cancers and other disorders that will provide the basis for finding genetic abnormalities in disease. Tumors specimens used in this study will be taken from tissues biopsied from patients with breast or ovarian cancer or melanoma as part of their routine care. Patients in the study will be among those receiving care at the: Department of Oncology, University Hospital, University of Lund, Sweden (breast cancer); Department of Medicine, University of Michigan, Ann Arbor, Michigan (breast cancer); Surgery Branch, National Cancer Institute, Bethesda, Maryland (melanoma). Patients in the study will have a family history taken and will complete a questionnaire. Some patients will be asked to have a blood test. Breast cancer patients will have a mammogram if one has not been done within the last year.
Details: The purpose of our study is to make use of a novel technology that the Cancer Genetics Branch of the NHGRI has been a leader in developing. This technology for genome-wide expression analysis, cDNA microarray hybridization, is the focus of our protocol. We will access tissue banks collected by our collaborators which contain excess tissues obtained during routine clinical care. Specimens will be processed for large scale gene expression analysis using cDNA microarrays. The development of this gene expression database is the primary purpose of this study. Currently available and new bioinformatics tools will be applied to the data for the characterization of disease subsets (e.g., early vs. advanced stage cancer) as well as to mine the data for specific genes which are linked to given disease states.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Clinical inclusion/exclusion criteria will be dependent upon the collaborating Institutions' requirements.
Total Enrollment: 1500
Location and Contact Information:
National Human Genome Research Institute (NHGRI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 990130; 99-HG-0130
Study Start Date: June 29, 1999
Record last reviewed: May 30, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001898
Other Hereditary Neoplastic Syndrome Studies:
1. Novel Adjuvants for Peptide-Based Melanoma Vaccines
2. Study of Talabostat in Advanced Melanoma
3. CTLA-4 Antibody (MDX-010) Plus Interleukin-2 to Treat Advanced Melanoma
4. Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
5. Treating Inoperable Lung Tumors With Heated Chemotherapy Medicine Delivered Solely to the Lung
Related Studies:
Other Hereditary Neoplastic Syndrome Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Microarray Analysis for Human Genetic Disease
|
|
|
|
|
|
|
|
